B
BioVie, Inc. Common StockBIVI
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage biopharmaceutical company focused on developing therapies for neurological disorders and advanced liver disease. Its lead candidate, bezisterim (NE3107), targets neuroinflammation and insulin resistance, which are believed to be key drivers of Alzheimer's and Parkinson's.
US StocksHealthcareSmall CapGrowth Stocks
BIVI の価格トレンド
BioVie, Inc. Common Stock · TradingView フルチャート
NASDAQ:BIVI